The Journal of Experimental Medicine
PBL InterferonSource
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online 26 June 2000.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 274K)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Felix, N. J.
Right arrow Articles by Ting, J. P.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Felix, N. J.
Right arrow Articles by Ting, J. P.-Y.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*Heart Transplantation
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/2000/7/31/ $5.00
The Journal of Experimental Medicine, Volume 192, Number 1, July 3, 2000 31-40

Original Article

H2-DM{alpha}-/- Mice Show the Importance of Major Histocompatibility Complex–bound Peptide in Cardiac Allograft Rejection

Nathan J. Felixa, W. June Brickeya, Robert Griffithsb, Jinghua Zhanga, Luc Van Kaerc, Thomas Coffmanb, and Jenny P.-Y. Tinga
a University of North Carolina Lineberger Comprehensive Cancer Center, Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599
b Department of Medicine and the Transplantation Laboratory, Durham Veterans Administration and Duke University Medical Center, Durham, North Carolina 27705
c Howard Hughes Medical Institute, Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232

Correspondence to: Jenny P.-Y. Ting, CB# 7295, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599-7295. Tel:919-966-5538 Fax:919-966-3015 E-mail:panyun{at}med.unc.edu.

The role played by antigenic peptides bound to major histocompatibility complex (MHC) molecules is evaluated with H2-DM{alpha}-/- mice. These mice have predominantly class II–associated invariant chain peptide (CLIP)-, not antigenic peptide–bound, MHC class II. H2-DM{alpha}-/- donor heart grafts survived three times longer than wild-type grafts and slightly longer than I-Aßb-/- grafts. Proliferative T cell response was absent, and cytolytic response was reduced against the H2-DM{alpha}-/- grafts in vivo. Residual cytolytic T cell and antibody responses against intact MHC class I lead to eventual rejection. Removal of both H2-DM{alpha} and ß2-microglobulin (ß2m) in cardiac grafts lead to greater (8–10 times) graft survival, whereas removal of ß2m alone did not have any effect. These results demonstrate the significance of peptide rather than just allogeneic MHC, in eliciting graft rejection.

Key Words: major histocompatibility complex class II, H2-DM, class II–associated antigenic peptide, alloreactivity, transplantation


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS